Stockscreener 앱 받기
67.60
0.82%
-0.56
시장 영업 전:
67.59
-0.010
-0.01%
Soleno Therapeutics Inc 주식(SLNO)의 최신 뉴스
Will Soleno Therapeutics Inc. (6XC) stock justify high valuationMarket Performance Report & Long-Term Capital Growth Strategies - newser.com
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action InvestigationSLNO - PR Newswire
How to escape a deep drawdown in Soleno Therapeutics Inc.Weekly Market Report & AI Powered Buy and Sell Recommendations - newser.com
Wells Fargo Reiterates a Buy Rating on Soleno Therapeutics (SLNO), Sets a PT of $123 - Insider Monkey
What Wall Street predicts for Soleno Therapeutics Inc. stock priceRecession Risk & AI Forecast Swing Trade Picks - newser.com
Can Soleno Therapeutics Inc. stock deliver sustainable ROEEarnings Summary Report & Capital Efficient Trading Techniques - newser.com
Detecting support and resistance levels for Soleno Therapeutics Inc.2025 Trading Volume Trends & Daily Growth Stock Tips - newser.com
How Soleno Therapeutics Inc. (6XC) stock stacks up against competitors2025 Market Outlook & Smart Money Movement Tracker - newser.com
Is Soleno Therapeutics Inc. stock supported by strong cash flows2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com
How Soleno Therapeutics Inc. stock performs in rate cut cycles2025 Support & Resistance & Momentum Based Trading Signals - newser.com
Momentum divergence signals in Soleno Therapeutics Inc. chartMarket Activity Recap & Safe Entry Trade Reports - newser.com
Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring an 82.77% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - WV News
Soleno Therapeutics Insiders Sold US$23m Of Shares Suggesting Hesitancy - 富途牛牛
SLNO Investor News: If You Have Suffered Losses in Soleno - GlobeNewswire
What analysts say about Soleno Therapeutics Inc stockTrading Volume Surges & Explore Stocks for Free with Our Research Portal - Early Times
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Baird reiterates Outperform rating on Soleno Therapeutics stock after rival’s trial failure - Investing.com Canada
Baird reiterates Outperform rating on Soleno Therapeutics stock after rival’s trial failure By Investing.com - Investing.com South Africa
SOLENO INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire Inc.
Wells Fargo Sticks to Their Buy Rating for Soleno Therapeutics (SLNO) - The Globe and Mail
Soleno Therapeutics (SLNO) Jumps 13.46% as Competitor Fails Prader-Willi Treatment Trial - MSN
2.36%
1.10%
자본화:
|
볼륨(24시간):